Ophthalmology

FDA Approves Preservative-Free Ophthalmic Solution for Eye Allergy Itch

September 25, 2020

Ketotifen fumarate ophthalmic solution 0.035% is the first and only over-the-counter preservative-free eye drop solution for itchy eyes caused by allergies.

Treatment Modifications Prevalent in Patients with Open-Angle Glaucoma

September 21, 2020

According to a retrospective claims database study, as many as 43.8% of assessed patients with open-angle glaucoma required a change from initial treatment.

Joshua Mali, MD: Hope for Patients with Wet AMD

September 18, 2020

Dr. Mali talks about advancements in treatment and screening for Wet AMD.

SRF Patterns Identified in Age-Related Macular Degeneration

September 18, 2020

More than half of the eyes observed in the study displayed collapse of the associated druse or drusenoid PED.

AI Screening for Diabetic Retinopathy Is Cost-Effective for At-Risk Children

September 03, 2020

At recommended adherence rates, automatic AI screening technology for diabetic retinopathy is a preferred strategy over conventional eye care professional screening.

Teleophthalmology Apps Extend Care in Combat Zones

August 27, 2020

The role of telehealth and teleophthalmology can continue to expand even after COVID-19.

Investigators Examine Link Between Ocular Symptoms and COVID-19 in Pediatric Patients

August 27, 2020

More than 20% of children examined in Wuhan showed various ocular manifestations.

FDA Clears New Drug Application for RGX-314 for Diabetic Retinopathy

August 26, 2020

A phase 2 trial will begin to evaluate the safety and efficacy of RGX-314.

FDA Approves Cysteamine Ophthalmic Solution for Cystinosis

August 25, 2020

This is the first and only FDA-approved cysteamine eye drop formulation, which is self-applied 4 times daily during waking hours.

Managing Glaucoma During COVID-19: Patients Point the Way to Improved Care

August 24, 2020

A new survey assessed patients’ confidence in their disease management during the pandemic, specific disease management concerns, and experiences with telemedicine.